APSR2026-710

 
Late-Breaking
Submitted
Poster Presentation
 
AP05-027
P130
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1221160-46904-PDF APSR 2026 Poster,minimally invasive approach to pulmonary aspergilloma _433862.pdf
Format: PDF Only
12. Bronchoscopy and Interventional Techniques
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Sharmin Sultana * National Institute of Diseases of the Chest and Hospital Respiratory Medicine Dhaka Bangladesh
Nirmal Sarkar - National Institute of Diseases of the Chest and Hospital Respiratory Medicine Dhaka Bangladesh
Hamza MD - National Institute of Diseases of the Chest and Hospital Respiratory Medicine Dhaka Bangladesh
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Sharmin
Sultana
drsharmin30@gmail.com
+8801934923604
41-50
Bangladesh
Case Report
"Minimally Invasive Approach to Pulmonary Aspergilloma:Intralesional Instillation of Voriconazole-A Successful Bronchoscopic Management of a case of recurrent Hemoptysis"
Maximum 25 words
Abstract Content
 
 
 
 
Pulmonary aspergilloma, a form of chronic pulmonary aspergillosis, results from the saprophytic colonization of Aspergillus fungi within a pre-existing pulmonary cavity, most commonly a sequela of treated tuberculosis.Pulmonary aspergilloma arising in patients with prior tubercular cavities can result in life-threatening hemoptysis. Although surgical intervention is curative, it is frequently high-risk or declined by patients.
A 54-year-old diabetic female with a previous history of disseminated tuberculosis who presented with massive hemoptysis. She was diagnosed with a right upper lobe aspergilloma and after declining surgery, underwent four sessions of bronchoscopic intralesional voriconazole instillation (200 mg in 20 mL normal saline, administered 30 days apart), followed by two months of oral voriconazole. The procedure was well-tolerated and free of complications. The patient experienced a significant reduction in hemoptysis (>50%) and symptomatic improvement. Radiological assessment at six months demonstrated partial reduction of the aspergilloma (<50%) and thinning of the cavity wall, confirming treatment success.
The management of pulmonary aspergilloma in patients unsuitable for surgical resection remains a significant clinical challenge. The present case of a 54-year-old female with a history of disseminated tuberculosis and diabetes illustrates this issue. She presented with recurrent, moderate-to-massive hemoptysis due to a right upper lobe aspergilloma and declined surgical intervention. Direct instillation of the drug into the cavity achieves high local concentrations, resulting in direct fungicidal action on the mycelia, reduced fungal burden, and subsequent shrinkage or stabilization of the aspergilloma . Our choice of voriconazole, the current drug of choice for most forms of aspergillosis , was supported by its excellent bioavailability and tolerability, which resulted in substantial clinical and radiological improvement.This case contributes to the growing body of evidence supporting intracavitary antifungal therapy as a safe, effective, and minimally invasive alternative for managing symptomatic aspergilloma in non-surgical candidates, offering a valuable option for hemoptysis control and improved clinical outcomes.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Pulmonary Aspergilloma, Voriconazole, Intralesional Therapy.
maximum 3 keywords and no abbreviations, separated by commas
 
302